लोड हो रहा है...
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
BACKGROUND: Programmed cell death-1 (PD-1) inhibitor has been indicated for many types of malignancies. However, these inhibitors also cause immune-related adverse events. Hepatobiliary disorder is a phenotype of immune-related adverse event affecting 0%–4.5% of patients treated with PD-1 inhibitors...
में बचाया:
| में प्रकाशित: | World J Gastroenterol |
|---|---|
| मुख्य लेखकों: | , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969883/ https://ncbi.nlm.nih.gov/pubmed/31988594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i3.353 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|